FDG PET/CT in Clinical Oncology
Case Based Approach with Teaching Points
Nonfiction, Health & Well Being, Medical, Medical Science, Biochemistry, Specialties, Oncology
| Author: | Jasna Mihailovic, Stanley J. Goldsmith, Ronan P. Killeen | ISBN: | 9783642298660 |
| Publisher: | Springer Berlin Heidelberg | Publication: | October 28, 2012 |
| Imprint: | Springer | Language: | English |
| Author: | Jasna Mihailovic, Stanley J. Goldsmith, Ronan P. Killeen |
| ISBN: | 9783642298660 |
| Publisher: | Springer Berlin Heidelberg |
| Publication: | October 28, 2012 |
| Imprint: | Springer |
| Language: | English |
FDG PET/CT has rapidly emerged as an invaluable combined imaging modality that provides both anatomic and functional information. This book, comprising a collection of images from oncology cases, is organized according to the role of FDG PET/CT in the evaluation and management of oncology patients, and only secondarily by organ or tumor entity. In this way, it reflects the issues that clinicians actually address, namely: identification of an unknown or unsuspected primary; determination of the extent of disease; evaluation of response to therapy; and surveillance after response, i.e., detection of recurrent disease. In total, 100 cases involving different primary tumors are presented to illustrate findings in these different circumstances. FDG PET/CT in Clinical Oncology will be of great value to all newcomers to this field, whether medical students, radiology, nuclear medicine, or oncology fellows, or practicing physicians.
FDG PET/CT has rapidly emerged as an invaluable combined imaging modality that provides both anatomic and functional information. This book, comprising a collection of images from oncology cases, is organized according to the role of FDG PET/CT in the evaluation and management of oncology patients, and only secondarily by organ or tumor entity. In this way, it reflects the issues that clinicians actually address, namely: identification of an unknown or unsuspected primary; determination of the extent of disease; evaluation of response to therapy; and surveillance after response, i.e., detection of recurrent disease. In total, 100 cases involving different primary tumors are presented to illustrate findings in these different circumstances. FDG PET/CT in Clinical Oncology will be of great value to all newcomers to this field, whether medical students, radiology, nuclear medicine, or oncology fellows, or practicing physicians.
